OpenAlex
PricingAboutJobs
Log inGet started
Work

Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients.

PubMed

Year: 2003
Type: article
Source: PubMed
Authors: Francisco Cervantes, Juan-Carlos Hernández-Boluda, Juan-Luis Steegmann, Eulogio Conde, Alberto Alvarez-Larrán, Javier López-Jiménez, Santiago Osorio, Lucía Villalón, Mireia Camós, Javier García-Conde, Jesús Odriozola
Institution: Hospital Clínic de Barcelona
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: imatinib mesylate, chronic myeloid leukemia, chronic phase, interferon resistance, progression-free survival, prognostic factors, cytogenetic response, hematologic response, platelet count, Sokal risk score, treatment discontinuation, neutropenia
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1761050310
FWCI: 2.249
Cites: 17
Cited by: 50
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security